HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Andreas H Jacobs Selected Research
Andreas H Jacobs Research Topics
Disease
41
Neoplasms (Cancer)
06/2022 - 10/2003
36
Glioma (Gliomas)
06/2022 - 02/2003
11
Glioblastoma (Glioblastoma Multiforme)
06/2022 - 10/2003
11
Neuroinflammatory Diseases
01/2022 - 05/2012
7
Brain Neoplasms (Brain Tumor)
06/2022 - 11/2004
5
Stroke (Strokes)
01/2022 - 11/2015
5
Infections
01/2021 - 02/2003
5
Alzheimer Disease (Alzheimer's Disease)
01/2020 - 03/2004
5
Parkinson Disease (Parkinson's Disease)
09/2019 - 03/2005
4
Lung Neoplasms (Lung Cancer)
01/2022 - 01/2008
4
Ischemia
01/2022 - 11/2020
4
Ischemic Stroke
01/2020 - 08/2004
3
Inflammation (Inflammations)
01/2022 - 01/2017
3
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 03/2004
3
Infarction (Infarctions)
01/2020 - 08/2004
3
Disease Progression
04/2015 - 02/2010
2
Gliosis
01/2023 - 11/2020
2
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2018
2
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2020 - 11/2015
2
Multiple Sclerosis
01/2019 - 05/2015
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2011 - 01/2008
2
Insulin Resistance
11/2006 - 03/2004
1
Acute Kidney Injury (Acute Renal Failure)
04/2022
1
Urinary Bladder Neoplasms (Bladder Cancer)
04/2022
1
Breast Neoplasms (Breast Cancer)
12/2021
1
Meningioma (Meningiomas)
12/2020
1
Primary angiitis of the central nervous system
01/2020
1
Dementia (Dementias)
07/2019
1
Delirium
07/2019
1
Deglutition Disorders (Dysphagia)
07/2019
1
Cognitive Dysfunction
07/2019
Drug/Important Bio-Agent (IBA)
15
Proteins (Proteins, Gene)
FDA Link
01/2023 - 05/2012
12
N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamide
IBA
01/2023 - 05/2012
11
alovudine
IBA
01/2022 - 12/2005
11
Biomarkers (Surrogate Marker)
IBA
12/2021 - 05/2012
9
Amino Acids
FDA Link
06/2022 - 11/2004
8
Methionine (L-Methionine)
FDA Link
01/2017 - 11/2004
7
Glucose (Dextrose)
FDA Link
Generic
06/2014 - 12/2005
6
Temozolomide (Temodar)
FDA Link
Generic
01/2021 - 05/2006
6
Gadolinium
IBA
05/2015 - 12/2005
5
acetamide
IBA
01/2022 - 12/2013
5
Thymidine
IBA
01/2018 - 01/2008
4
Therapeutic Uses
IBA
01/2021 - 10/2003
4
Matrix Metalloproteinases (MMPs)
IBA
11/2020 - 11/2015
4
Ganciclovir (Cytovene)
FDA Link
Generic
11/2007 - 02/2003
3
Ligands
IBA
01/2017 - 11/2009
3
ErbB Receptors (EGF Receptor)
IBA
05/2011 - 11/2005
3
Thymidine Kinase
IBA
11/2007 - 03/2005
2
gamma-glutamylaminomethylsulfonic acid (GAMS)
IBA
06/2022 - 01/2020
2
pyrimidine
IBA
01/2022 - 01/2022
2
Indicators and Reagents (Reagents)
IBA
01/2022 - 07/2012
2
Antineoplastic Agents (Antineoplastics)
IBA
01/2022 - 11/2006
2
Macrophage Colony-Stimulating Factor
IBA
01/2022 - 01/2022
2
thymidine kinase 1
IBA
01/2021 - 01/2017
2
Nitric Oxide (Nitrogen Monoxide)
FDA Link
01/2021 - 01/2016
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2020 - 12/2005
2
Thymidylate Synthase
IBA
01/2018 - 12/2016
2
Caspase 3 (Caspase-3)
IBA
12/2016 - 06/2014
2
Dopamine (Intropin)
FDA Link
Generic
01/2016 - 10/2006
2
Enzymes
IBA
11/2015 - 05/2015
2
Pentetic Acid (DTPA)
FDA Link
Generic
05/2015 - 12/2011
2
Acids
IBA
05/2015 - 01/2010
2
Tyrosine (L-Tyrosine)
FDA Link
07/2013 - 03/2013
2
Small Interfering RNA (siRNA)
IBA
03/2013 - 11/2005
2
Pioglitazone (Actos)
FDA Link
01/2013 - 11/2006
2
Gadolinium DTPA (Magnevist)
FDA Link
12/2011 - 01/2010
2
Green Fluorescent Proteins
IBA
06/2011 - 02/2003
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
05/2011 - 01/2008
2
Guanine
IBA
11/2007 - 07/2007
2
9-(4-fluoro-3-hydroxymethylbutyl)guanine
IBA
07/2007 - 02/2007
2
Prodrugs
IBA
02/2007 - 02/2003
1
Amines
IBA
01/2022
1
PLX5622
IBA
01/2022
1
Radiopharmaceuticals
IBA
12/2021
1
Thiobarbituric Acid Reactive Substances
IBA
01/2021
1
Metformin (Glucophage)
FDA Link
Generic
01/2021
1
3,4-dihydroxyphenylethanol (hydroxytyrosol)
IBA
01/2021
1
VC701 compound
IBA
01/2021
1
C-Reactive Protein
IBA
12/2020
1
HLA-DR Antigens (HLA-DR)
IBA
01/2020
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2020
1
ethyl tyrosine ester
IBA
01/2020
1
Purinergic P2X7 Receptors
IBA
09/2019
1
Ion Channels (Ion Channel)
IBA
09/2019
1
Adenosine Triphosphate (ATP)
IBA
09/2019
1
Cholinesterase Inhibitors (Anticholinesterases)
IBA
07/2019
1
Memantine (Namenda)
FDA Link
07/2019
1
entinostat (MS 275)
IBA
03/2019
Therapy/Procedure
33
Therapeutics
06/2022 - 04/2005
6
Drug Therapy (Chemotherapy)
01/2020 - 05/2006
4
Aftercare (After-Treatment)
01/2016 - 04/2005
4
Radiotherapy
03/2013 - 01/2008
1
Polypharmacy
01/2022
1
Precision Medicine
12/2021
1
Mediterranean Diet
01/2021
1
Immunomodulation
01/2021
1
Artificial Respiration (Mechanical Ventilation)
12/2020
1
Immunotherapy
01/2020
1
Combined Modality Therapy
10/2019
1
Length of Stay
07/2019